PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTIONS BETWEEN HSR-803 AND WARFARIN IN HEALTHY SUBJECTS

被引：0
|
作者：
Rufiange, M. [1 ]
Massicotte, J. [1 ]
Sicard, E. [1 ]
Lefebvre, M. [1 ]
机构：
[1] Algorithme Pharma Inc, Laval, PQ, Canada
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2013年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S105 / S105
页数：1
相关论文
共 50 条
  • [41] NO PHARMACOKINETIC OR PHARMACODYNAMIC INTERACTION BETWEEN RIVASTATIN AND WARFARIN
    SCHALL, R
    MULLER, FO
    HUNDT, HKL
    RITTER, W
    DUURSEMA, L
    GROENEWOUD, G
    MIDDLE, MV
    JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 35 (03): : 306 - 313
  • [42] Pharmacokinetic/pharmacodynamic modeling of pegfilgrastim in healthy subjects
    Roskos, Lorin K.
    Lum, Peggy
    Lockbaum, Pamela
    Schwab, Gisela
    Yang, Bing-Bing
    JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (07): : 747 - 757
  • [43] Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects
    Abdul, M. I. Mohammed
    Jiang, X.
    Williams, K. M.
    Day, R. O.
    Roufogalis, B. D.
    Liauw, W. S.
    Xu, H.
    McLachlan, A. J.
    BRITISH JOURNAL OF PHARMACOLOGY, 2008, 154 (08) : 1691 - 1700
  • [44] Pharmacodynamic and Pharmacokinetic Drug Interactions between Fexuprazan, a Novel Potassium-Competitive Inhibitor, and Aspirin, in Healthy Subjects
    Oh, JungJin
    Yang, Eunsol
    Jang, In-Jin
    Lee, Hyejung
    Yoo, Hokyun
    Chung, Jae-Yong
    Lee, SeungHwan
    Oh, Jaeseong
    PHARMACEUTICS, 2023, 15 (02)
  • [45] Pharmacokinetic and pharmacodynamic interactions between metformin and a novel dipeptidyl peptidase-4 inhibitor, evogliptin, in healthy subjects
    Rhee, Su-jin
    Choi, YoonJung
    Lee, SeungHwan
    Oh, Jaeseong
    Kim, Sung-Jin
    Yoon, Seo Hyun
    Cho, Joo-Youn
    Yu, Kyung-Sang
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 2525 - 2534
  • [46] A systematic review of the pharmacokinetic and pharmacodynamic interactions of herbal medicine with warfarin
    Choi, Songie
    Oh, Dal-Seok
    Jerng, Ui Min
    PLOS ONE, 2017, 12 (08):
  • [47] Pharmacokinetic, Pharmacokinetic/Pharmacodynamic, and Safety Investigations of Cefiderocol in Chinese Healthy Subjects
    Zhang, Chuhan
    Yu, Shuyan
    Li, Size
    Wu, Xiaojie
    Wei, Qiong
    He, Jinjie
    Cao, Guoying
    Yang, Haijing
    Wang, Jingjing
    Fujitani, Kohei
    Katsube, Takayuki
    Zhang, Jing
    Dou, Honghong
    ADVANCES IN THERAPY, 2025, : 2285 - 2297
  • [48] Pharmacokinetic, Pharmacokinetic/Pharmacodynamic, and Safety Investigations of Lefamulin in Healthy Chinese Subjects
    Hu, Yingying
    Wei, Qiong
    Bian, Xingchen
    Yang, Xinyi
    Yu, Jicheng
    Wang, Jingjing
    Yang, Haijing
    Cao, Guoying
    Wu, Xiaojie
    Zhang, Jing
    ANTIBIOTICS-BASEL, 2023, 12 (09):
  • [49] Lack of pharmacokinetic and pharmacodynamic interaction between valsartan and warfarin
    Knight, H
    Flesch, G
    Prasad, P
    Lloyd, P
    Douglas, J
    JOURNAL OF HYPERTENSION, 2000, 18 : S89 - S89
  • [50] Pharmacokinetic and pharmacodynamic interaction of dronedarone and dabigatran in healthy subjects
    Brunet, A.
    Hermabessiere, S.
    Benain, X.
    EUROPEAN HEART JOURNAL, 2011, 32 : 618 - 619
12345